Risk factors for loss to follow-up from antiretroviral therapy programmes in low-income and middle-income countries
Open accessThe DOI matches its Crossref record; 124 of the 125 references it cites were found in a registry or an index.
Abstract
Introduction: Loss to follow-up (LTFU) rates from antiretroviral treatment (ART) programmes in low- and middle-income countries (LMIC) are high, leading to poor treatment outcomes and onward transmission of HIV. Knowledge of risk factors is required to address LTFU. In this systematic review, risk factors for LTFU are identified and meta-analyses performed. Methods: PubMed, Embase, Psycinfo and Cochrane were searched for studies that report on potential risk factors for LTFU in adults who initiated ART in LMICs. Meta-analysis was performed for risk factors evaluated by at least five studies. Pooled effect estimates and their 95% confidence intervals (95% CI) were calculated using random effect models with inverse variance weights. Risk of bias was assessed and sensitivity analyses performed. Results: Eighty studies were included describing a total of 1 605 320 patients of which 87.4% from sub-Saharan Africa. The following determinants were significantly associated with an increased risk of LTFU in meta-analysis: male sex, older age, being single, unemployment, lower educational status, advanced WHO stage, low weight, worse functional status, poor adherence, nondisclosure, not receiving cotrimoxazole prophylactic therapy when indicated, receiving care at secondary level and more recent year of initiation. No association was seen for CD4+ cell count, tuberculosis at baseline, regimen, and geographical setting. Conclusion: There are several sociodemographic, clinical, patient behaviour, treatment-related and system level risk factors for LTFU from ART programs. Knowledge of risk factors should be used to better target retention interventions and develop tools to identify high-risk patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Losses in follow-up rates in LMICs, especially in sub-Saharan Africa, for any condition are known to be high due to multiple factors [37-39].”
From An mHealth App (eSkinHealth) for detecting and managing skin diseases in resource-limited settings: mixed methods Pilot Study (2023) · cites this paper as [38]
Citations
Cites
Impact of HIV‐related stigma on treatment adherence: systematic review and meta‐synthesis
Katz, I. T., Ryu, A. E., Onuegbu, A. G., Psaros, C., Weiser, S. D., Bangsberg, D. R., & Tsai, A. C. (2013) · Journal of the International AIDS Society · doi:10.7448/ias.16.3.18640 · Cited by 1,126
Adherence to Nonnucleoside Reverse Transcriptase Inhibitor–Based HIV Therapy and Virologic Outcomes
Nachega, J. B., Hislop, M., Dowdy, D. W., Chaisson, R. E., Regensberg, L., & Maartens, G. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-8-200704170-00007 · Cited by 374
Fox, M. P., & Rosen, S. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000553 · Cited by 306
Mugglin, C., Estill, J., Wandeler, G., Bender, N., Egger, M., Gsponer, T., Keiser, O., & Africa, F. I. S. (2012) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2012.03089.x · Cited by 250
Cornell, M., Schomaker, M., Garone, D. B., Giddy, J., Hoffmann, C. J., Lessells, R., Maskew, M., Prozesky, H., Wood, R., Johnson, L. F., et al. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001304 · Cited by 244
Cornell, M., Grimsrud, A., Fairall, L., Fox, M. P., van Cutsem, G., Giddy, J., Wood, R., Prozesky, H., Mohapi, L., Graber, C., et al. (2010) · AIDS · doi:10.1097/qad.0b013e32833d45c5 · Cited by 223
Influence of gender on loss to follow-up in a large HIV treatment programme in western Kenya
Ochieng-Ooko, V., Ochieng, D., Sidle, J. E., Holdsworth, M., Wools-Kaloustian, K., Siika, A. M., Yiannoutsos, C. T., Owiti, M., Kimaiyo, S., & Braitstein, P. (2010) · Bulletin of the World Health Organization · doi:10.2471/blt.09.064329 · Cited by 196
Vagenas, P., Azar, M. M., Copenhaver, M. M., Springer, S. A., Molina, P. E., & Altice, F. L. (2015) · Current HIV/AIDS Reports · doi:10.1007/s11904-015-0285-5 · Cited by 189
Toure, S., Kouadio, B., Seyler, C., Traore, M., Dakoury-Dogbo, N., Duvignac, J., Diakite, N., Karcher, S., Grundmann, C., Marlink, R., et al. (2008) · AIDS · doi:10.1097/qad.0b013e3282f768f8 · Cited by 185
Evans, D., Menezes, C., Mahomed, K., Macdonald, P., Untiedt, S., Levin, L., Jaffray, I., Bhana, N., Firnhaber, C., & Maskew, M. (2013) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2012.0215 · Cited by 172
Research works printed but not linked: 2
- Wilkinson, 2015, Self-transfer and mortality amongst adults lost to follow-up in ART programmes in low- and middle-income countries: systematic review and meta-analysis, Trop Med Int Health, 20, 365, 10.1111/tmi.12434 · DOI · Paper page
- Sikombe, 2018, Understanding patient mobility in HIV +VE adults across multiple clinics in Zambia, Top Antivir Med, 26, 503s
Cited by
The case for an HIV cure and how to get there
Dybul, M., Attoye, T., Baptiste, S., Cherutich, P., Dabis, F., Deeks, S. G., Dieffenbach, C., Doehle, B., Goodenow, M. M., Jiang, A., et al. (2021) · The Lancet HIV · doi:10.1016/s2352-3018(20)30232-0 · Cited by 98
Muhula, S. O., Gachohi, J. M., Kombe, Y., & Karanja, S. M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0263663 · Cited by 42
Bantie, B., Seid, A., Kerebeh, G., Alebel, A., & Dessie, G. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.876430 · Cited by 32
Inzaule, S. C., Kroeze, S., Kityo, C. M., Siwale, M., Akanmu, S. A., Wellington, M., de Jager, M., Ive, P., Mandaliya, K. N., Stevens, W. S., et al. (2022) · AIDS · doi:10.1097/qad.0000000000003270 · Cited by 31
Telayneh, A. T., Tesfa, M., Woyraw, W., Temesgen, H., Alamirew, N. M., Haile, D. H., Tafere, Y., & Petrucka, P. M. (2022) · Scientific Reports · doi:10.1038/s41598-022-07049-y · Cited by 28
Metadata
- Authors
- Frijters, E. M., Hermans, L. E., Wensing, A. M. J., Devillé, W. L. J. M., Tempelman, H. A., & De Wit, J. B. F.
- Affiliations
- University Medical Center Utrecht (NL)
- University of the Witwatersrand (ZA)
- Department of Interdisciplinary Social Science, Utrecht University, the Netherlands
- Venue
- AIDS
- Published
- 2020-04-13
- Volume
- 34
- Issue
- 9
- Pages
- 1261-1288
- ISSN
- 0269-9370 (ISSN-L)
- 1473-5571
- OpenAlex
- W3015269463
- Cited by
- 75
- References
- 125
- Citations by year
- 2026: 9 · 2025: 14 · 2024: 11 · 2023: 11 · 2022: 17 · 2021: 10 · 2020: 2
- FWCI
- 0.47
- Type
- journal article
- Language
- en
- Open access
- green
- dspace.library.uu.nl
- Licence
- other-oa
- Locations
- AIDS (publishedVersion)
- PubMed (publishedVersion)
- UvA-DARE (University of Amsterdam) (publishedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › HIV/AIDS Impact and Responses
- Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
- Keywords
- loss to follow-up, antiretroviral therapy, HIV, risk factors, retention in care, sociodemographic factors, medication adherence, HIV non-disclosure, cotrimoxazole prophylaxis, WHO clinical stage, low- and middle-income countries, sub-Saharan Africa
- MeSH terms
- Retention in Care, Adult, Aged, Humans, Male, Risk Factors, HIV Infections, Africa South of the Sahara, Anti-HIV Agents, Antiretroviral Therapy, Highly Active, Medication Adherence, Lost to Follow-Up
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Risk factors for loss to follow-up from antiretroviral therapy programmes in low-income and middle-income countries. https://app.cochat.ai/papers/10.1097/qad.0000000000002523
- The paper
- Frijters, E. M., Hermans, L. E., Wensing, A. M. J., Devillé, W. L. J. M., Tempelman, H. A., & De Wit, J. B. F. (2020). Risk factors for loss to follow-up from antiretroviral therapy programmes in low-income and middle-income countries. AIDS. https://doi.org/10.1097/qad.0000000000002523
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.